10/01/2024
Opioids can be effective for pain relief when used as prescribed, but they also carry the risk of dependence, misuse, and addiction, with factors like genetics playing a role. AvertD, an FDA-approved test, uses DNA from buccal swabs to determine whether they have a specific set of genetic variants that may be associated with an elevated genetic risk of developing opioid use disorder (OUD). AvertD can be a crucial part of assessing a patient’s risk for OUD within a comprehensive clinical evaluation.
Learn more about AvertD by SOLVD Health: https://avertdtest.com/
